Concepedia

Raymond Fink

RF

Statistics

Publications

14

Citations

2K

H-Index

14

Active since

1983

Affiliations

University of Chicago(Current)

Universidad Europea de Madrid

University of Michigan

National and Kapodistrian University of Athens

Bayer (Germany)

Raymond Fink is an author at University of Chicago specializing in medicine, diabetes mellitus, and endocrinology.

Publications per year

1983–2023

14

Publications

14

Mechanisms of Insulin Resistance in Aging

Raymond Fink, Orville Kolterman, Jennifer J. Griffin et al. · Journal of Clinical Investigation · 1983 · 552 citations · Full text

Medicine, Endocrinology, Physiology +16

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of Aging on Insulin Secretion

Barry Gumbiner, Kenneth S. Polonsky, W F Beltz et al. · Diabetes · 1989 · 127 citations

Medicine, Endocrinology, Physiology +15

1–5 of 14